Cost Effectiveness of Intermittent Preventive Treatment of Malaria in Infants in Ghana.

Simple item page
dc.contributor.authorAbotsi, Anselm Komla
dc.contributor.authorInkoom, Ebenezer
dc.contributor.authorRibaira, Eric
dc.contributor.authorMentec, Rozenn Le
dc.contributor.authorLevy, Pierre
dc.contributor.authorLafarge, Herve
dc.contributor.authorde Sousa Alexandra
dc.date.accessioned2014-07-25T05:40:13Z
dc.date.available2014-07-25T05:40:13Z
dc.date.issued2012-01
dc.description.abstractAim: In order to integrate malaria Intermittent Preventive Treatment in infants (IPTi) into the Ghana national immunization programme, there was the need to evaluate the feasibility of IPTi by assessing the intervention operational issues including its implementation costs, and its cost effectiveness. Study Design: Cross-sectional study. Place and Duration of Study: Upper East Region, Ghana, between July 2007 and July 2009 Methods: We calculated the costs of administrating IPTi during vaccination sessions; the costs of programme implementation during the first year of implementation (start-up costs) and in routine years (recurrent costs). For the purposes of cost-effectiveness analysis, all economic costs (including financial and opportunity costs) and the net cost were estimated. To estimate the cost effectiveness ratios of IPTi, the aggregate cost of providing the intervention for a reference target population of 1,000 infants was divided by its health outcome. Sensitivity analyses were carried out to understand the results robustness. Results: IPTi gross costs in start up and in routine years were estimated at 70.66 cents and 29.72 cents per dose, or $2.0 and $0.87 per infant, respectively. The gross cost per DALY saved was estimated at $3.49 and the net cost of IPTi for 1,000 infants was $-3,416.38 in the routine years rending IPTi a highly cost saving intervention. Sensitivity analyses showed that the cost per DALY saved never went up more than $4.50 maintaining the intervention still highly cost effective. Conclusion: IPTi in Ghana is a highly and robust cost effective intervention. The intervention is cost-saving and should be scaled up nationally to save children’s health and economic capital.en_US
dc.identifier.citationAbotsi Anselm Komla, Inkoom Ebenezer, Ribaira Eric, Mentec Rozenn Le, Levy Pierre, Lafarge Herve, de Sousa Alexandra. Cost Effectiveness of Intermittent Preventive Treatment of Malaria in Infants in Ghana. International Journal of TROPICAL DISEASE & Health. 2012 Jan-Mar; 2(1): 1-15.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/153111
dc.language.isoenen_US
dc.source.urihttps://www.sciencedomain.org/abstract.php?iid=110&id=19&aid=397en_US
dc.subjectMalariaen_US
dc.subjectintermittent preventive treatment in infantsen_US
dc.subjecthealth outcomeen_US
dc.subjectdirect delivery costen_US
dc.subjectindirect delivery costen_US
dc.subjecteconomic costen_US
dc.subjectincremental costsen_US
dc.subjectcost effectiveness analysisen_US
dc.titleCost Effectiveness of Intermittent Preventive Treatment of Malaria in Infants in Ghana.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijtdh2012v2n1p1.pdf
Size:
237.13 KB
Format:
Adobe Portable Document Format
Description:
Research article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
International Journal of TROPICAL DISEASE & Health